| Literature DB >> 18571929 |
Thota Ganesh1, Jaeki Min, Pahk Thepchatri, Yuhong Du, Lian Li, Iestyn Lewis, Larry Wilson, Haian Fu, Gabriela Chiosis, Raymond Dingledine, Dennis Liotta, James P Snyder, Aiming Sun.
Abstract
The molecular chaperone Hsp90 plays important roles in maintaining malignant phenotypes. Recent studies suggest that Hsp90 exerts high-affinity interactions with multiple oncoproteins, which are essential for the growth of tumor cells. As a result, research has focused on finding Hsp90 probes as potential and selective anticancer agents. In a high-throughput screening exercise, we identified quinoline 7 as a moderate inhibitor of Hsp90. Further hit identification, SAR studies, and biological investigation revealed several synthetic analogs in this series with micromolar activities in both fluorescent polarization (FP) assay and a cell-based Western blot (WB) assay. These compounds represent a new class of Hsp90 inhibitors with simple chemical structures.Entities:
Mesh:
Substances:
Year: 2008 PMID: 18571929 PMCID: PMC2553564 DOI: 10.1016/j.bmc.2008.05.047
Source DB: PubMed Journal: Bioorg Med Chem ISSN: 0968-0896 Impact factor: 3.641